Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent Deferred RevenueLiabilities and Shareholders EquityNon-Current AssetsNon-Current Deffered RevenueOperating LeasesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Gossamer Bio (GOSS) Non-Current Debt: 2022-2023

Historic Non-Current Debt for Gossamer Bio (GOSS) over the last 2 years, with Dec 2023 value amounting to $814,000.

  • Gossamer Bio's Non-Current Debt fell 93.21% to $814,000 in Q4 2023 from the same period last year, while for Dec 2023 it was $814,000, marking a year-over-year decrease of 93.21%. This contributed to the annual value of $814,000 for FY2023, which is 93.21% down from last year.
  • Gossamer Bio's Non-Current Debt amounted to $814,000 in FY2023, which was down 93.21% from $12.0 million recorded in FY2022.
  • Over the past 5 years, Gossamer Bio's Non-Current Debt peaked at $12.0 million during FY2022, and registered a low of $814,000 during FY2023.
  • Moreover, its 2-year median value for Non-Current Debt was $6.4 million (2022), whereas its average is $6.4 million.
  • Data for Gossamer Bio's Non-Current Debt shows a maximum YoY crashed of 93.21% (in 2023) over the last 5 years.
  • Over the past 2 years, Gossamer Bio's Non-Current Debt (Yearly) stood at $12.0 million in 2022, then crashed by 93.21% to $814,000 in 2023.